Contributions
Abstract: PB1756
Type: Publication Only
Session title: Quality of life, palliative care, ethics and health economics
Background
Cochrane Haematology produces, publishes and maintains systematic reviews in the field of haematology. The group wants to ensure that their limited resources and efforts are being used to produce Cochrane reviews addressing topics that are of utmost importance to their end-users. According to one of Cochrane’s key principle ‘striving for relevance’ the group initialised their first priority setting exercise engaging stakeholders worldwide to identify the top priority topics for Cochrane Haematology reviews.
Aims
To identify the top ten priority topics for review updates and the top five priority topics for new Cochrane Haematology reviews as part of Cochrane Haematology’s priority setting exercise.
Methods
The priority setting exercise consisted of two phases. In phase one, potential priority topics were generated by identifying trends (analysing review metrics) and gaps (screening for priority topics of the American Society of Hematology (ASH), the European Hematology Association (EHA), the German Society for Hematology and Oncology (DGHO) and the James Lind Alliance (JLA) in the field of hematology) in the current review portfolio. In the second phase, the identified topics were then prioritised by various stakeholders in an online survey. Respondents were asked to select the topics they deemed to be of high priority and rank them afterwards from highest to lowest priority. An average score was then calculated for each ranked topic. Topics with the highest average score were identified as being the top priority topics.
Results
The online survey was open between July 6th 2020 to August 28th 2020. A total of 160 responses were collected, of which 63 respondents (39%) provided complete responses. Most of the respondents identified themselves as physician (34%), someone who is or has been affected by haematological disease (31%), or researcher (24%) and were distributed across 21 countries. The highest number of respondents resided in the United Kingdom (n = 72), Germany (n = 20) and Canada (n = 11). The top ten priority topics for reviews that need updating were related to interventions in multiple myeloma, hodgkin lymphoma and topics from the areas of stem cell transplantation and supportive care for haematological diseases. The top five priority topics for new reviews addressed mainly myelodysplastic syndrome (MDS), relapse of disease post-haematopoietic stem cell transplant and long-term survival in cancer.
Conclusion
The priority setting process engaged various stakeholders and identified the most relevant review topics, published on Cochrane Haematology’s website. These topics, some of them are open to new authors, will now guide the group’s future scope of work and ensure that the most important reviews are updated. New priority reviews will close gaps within the review portfolio of Cochrane Haematology.
Keyword(s): Systematic review
Abstract: PB1756
Type: Publication Only
Session title: Quality of life, palliative care, ethics and health economics
Background
Cochrane Haematology produces, publishes and maintains systematic reviews in the field of haematology. The group wants to ensure that their limited resources and efforts are being used to produce Cochrane reviews addressing topics that are of utmost importance to their end-users. According to one of Cochrane’s key principle ‘striving for relevance’ the group initialised their first priority setting exercise engaging stakeholders worldwide to identify the top priority topics for Cochrane Haematology reviews.
Aims
To identify the top ten priority topics for review updates and the top five priority topics for new Cochrane Haematology reviews as part of Cochrane Haematology’s priority setting exercise.
Methods
The priority setting exercise consisted of two phases. In phase one, potential priority topics were generated by identifying trends (analysing review metrics) and gaps (screening for priority topics of the American Society of Hematology (ASH), the European Hematology Association (EHA), the German Society for Hematology and Oncology (DGHO) and the James Lind Alliance (JLA) in the field of hematology) in the current review portfolio. In the second phase, the identified topics were then prioritised by various stakeholders in an online survey. Respondents were asked to select the topics they deemed to be of high priority and rank them afterwards from highest to lowest priority. An average score was then calculated for each ranked topic. Topics with the highest average score were identified as being the top priority topics.
Results
The online survey was open between July 6th 2020 to August 28th 2020. A total of 160 responses were collected, of which 63 respondents (39%) provided complete responses. Most of the respondents identified themselves as physician (34%), someone who is or has been affected by haematological disease (31%), or researcher (24%) and were distributed across 21 countries. The highest number of respondents resided in the United Kingdom (n = 72), Germany (n = 20) and Canada (n = 11). The top ten priority topics for reviews that need updating were related to interventions in multiple myeloma, hodgkin lymphoma and topics from the areas of stem cell transplantation and supportive care for haematological diseases. The top five priority topics for new reviews addressed mainly myelodysplastic syndrome (MDS), relapse of disease post-haematopoietic stem cell transplant and long-term survival in cancer.
Conclusion
The priority setting process engaged various stakeholders and identified the most relevant review topics, published on Cochrane Haematology’s website. These topics, some of them are open to new authors, will now guide the group’s future scope of work and ensure that the most important reviews are updated. New priority reviews will close gaps within the review portfolio of Cochrane Haematology.
Keyword(s): Systematic review